Keywords: Teva, Lilly, Watson, Sanofi-Aventis, Gemzar, Seasonique, Eloxatin, Hospira, Par Phrma, Actavis

Teva gets mixed news on patent disputes; fails over Gemzar with Lilly, prevails in fight with Watson: Sanofi in more Eloxatin settlements

Article | 06 April 2010

Print This

A federal judge in the USA has ruled that Teva Pharmaceuticals USA’s Abbreviated New Drug Applications for the cancer ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in